Chronic HF
|
|
|
Seattle Heart Failure Model
19
(2006)
|
Age, Sex, LVEF, NYHA Class, Weight, SBP, Labs (Hgb, Lymphs, UA, Chol, Na), Wide QRS/LBBB, Meds (including GDMT, allopurinol, statins, diuretics), Devices (ICD/CRT/PPM) |
1, 2, and 5-year mortality |
CHARM Risk Score
26
(2006)
|
Age, Sex, LVEF, NYHA Class, BMI, DM, AF, MR, MI, Prior HF hosp, HF duration, Current smoker, DBP, HR, Dependent edema, Pulmonary crackles, Dyspnea, Pulmonary edema, Cardiomegaly, ARB |
All-cause mortality; CV death or HF hosp |
CORONA Risk Score
27
(2009)
|
Age, Sex, LVEF, NYHA Class, BMI, DM, MI, CABG, AF, Claudication, HR, NT-proBNP, Cr, ApoA-1 |
CV death, non-fatal MI, or stroke |
GISSI-HF Model
28
(2013)
|
Age, Sex, LVEF, NYHA Class, BMI, DM, COPD, AS, SBP, Labs (eGFR, Hgb, UA, NT-proBNP, hs-CTnT) |
All-cause mortality |
MAGGIC Risk Score
23
(2013)
|
Age, Sex, LVEF, NYHA class, BMI, DM, COPD, Recent diagnosis, Smoking status, SBP, Cr, Meds (B-blockers, ACEi/ARB) |
1 and 3-year all-cause mortality |
PARADIGM Risk Score
29
(2020)
|
Age, Sex, Race, LVEF, NYHA Class, BMI, DM, Region, HF duration, HF hosp, MI, Valve dz, BBB, PCI, PAD, SBP, Bili, AST, UA, Alb, K, Cl, Hgb, LDL, Trig, BUN, WBCs, NT-proBNP, B-blocker, ARNI |
CV Death or HF Hosp; CV death; All-cause death |
Hospitalized HF
|
|
|
EFFECT Model
138
(2003)
|
Age, COPD, Cirrhosis, Cancer, Dementia, Cerebrovascular dz, SBP, RR, Na, BUN, Hgb |
30-day and 1-year mortality |
OPTIME-CHF Model
9
(2004)
|
Age, NYHA Class, SBP, BUN, Na Prior HF hosp, SBP, BUN, h/o PCI |
60-day mortality 60-day readmission |
ADHERE CART Model
4
(2005)
|
SBP, BUN, Creatinine |
In-hospital mortality |
OPTIMIZE-HF Nomogram
38,39
(2008)
|
Age, LVEF, HF primary diagnosis, HR, SBP, Na, Cr Age, Weight, SBP, Na, Cr, Liver dz, Depression, Reactive airway dz |
In-hospital mortality 60-day mortality or readmission |
GWTG-HF Score
5
(2010)
|
Age, Race, COPD, SBP, HR, Na, BUN |
In-hospital mortality |
ESCAPE Risk Score
6
(2010)
|
Age, CPR/mechanical ventilation, Na, BNP, BUN, Diuretic, B-Blocker, 6MWT |
6-month mortality |
Refractory HF Risk Score
59
(2011)
|
Age, DM, Stroke, Arrhythmia, Na, BNP, BUN, Betablocker, KCCQ Score |
Unfavorable QOL or death at 6 months |
PROTECT HF Post-discharge Model
40
(2014)
|
Age, SBP, Na, Cr, BUN, Albumin, Prior HF Hosp, Peripheral edema |
30/180-day mortality, All-cause Hosp, and/or CV Hosp |
BIOSTAT-CHF Model
41
(2017)
|
Age, BUN, NT-proBNP, Hgb, B-blocker Age, prior HF hosp, edema, SBP, eGFR |
All-cause mortality HF hosp |
HFpEF
|
|
|
I-PRESERVE Score
46
(2011)
|
Age, LVEF, Ischemic etiology, Prior HF hosp, QOL, DM, MI, COPD/asthma, HR, eGFR, Neutrophils, NT-proBNP |
All-cause mortality or CV hosp, all-cause mortality, HF hosp or mortality |
ARIC Score
47
(2017)
|
Modified EFFECT score + Race, BMI, AF, HR, Hypoxia, Natriuretic peptides |
28-day and 1-year mortality |